Position in RYTM
as of Mar 31, 2026
· filed May 12, 2026
Position Value
$21,557,775
+$3,942,952 QoQ
Shares Held
247,876
+50.6% QoQ
Ownership
0.362%
of shares outstanding
% of Portfolio
0.02%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 0.ToString("F0")%
Shared 100.ToString("F0")%
None 0.ToString("F0")%
Common Shares in RYTM Over Time
Shares Held
Position Value (USD)
Derivatives in RYTM
reported options exposure · as of Mar 31, 2023CallValue
$10,846
CallShares
608
PutValue
$0
PutShares
0
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Biotechnology
Healthcare · as of Mar 31, 2026BNP PARIBAS ARBITRAGE, SA holds $2,946,330,584 across 411 Biotechnology names. RYTM ranks #33 (0.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
448,371 | $346,429,369 | |
| 2 | MRNA |
Moderna, Inc.
|
4,317,219 | $219,314,725 | |
| 3 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
415,625 | $185,593,187 | |
| 4 | BNTX |
BioNTech SE
|
1,651,789 | $146,811,006 | |
| 5 | ARGX |
Argenx SE
|
177,836 | $129,864,739 | |
| 6 | INSM |
INSMED Inc
|
604,600 | $98,864,192 | |
| 7 | BBIO |
BridgeBio Pharma, Inc.
|
1,307,176 | $97,070,889 | |
| 8 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
280,965 | $92,962,889 |
All Filings in RYTM
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $21,557,775 | 247,876 | Shares | Defined | 2026-05-12 | |
| 2025-12-31 | $17,614,823 | 164,563 | Shares | Defined | 2026-02-10 | |
| 2025-09-30 | $22,589,544 | 223,681 | Shares | Defined | 2025-11-13 | |
| 2025-06-30 | $6,460,482 | 102,239 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $4,558,916 | 86,066 | Shares | Defined | 2025-05-14 | |
| 2024-12-31 | $4,772,239 | 85,249 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $755,725 | 14,425 | Shares | Defined | 2024-11-13 | |
| 2024-06-30 | $145,475 | 3,543 | Shares | Defined | 2024-08-13 | |
| 2024-03-31 | $2,426,869 | 56,009 | Shares | Defined | 2024-05-01 | |
| 2023-12-31 | $2,900,017 | 63,085 | Shares | Defined | 2024-02-14 | |
| 2023-09-30 | $1,266,445 | 55,243 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $879,823 | 53,355 | Shares | Defined | 2023-08-09 | |
| 2023-03-31 | $10,846 | 608 | Call | Defined | 2023-05-12 | |
| 2023-03-31 | $1,552,829 | 87,042 | Shares | Defined | 2023-05-12 | |
| 2022-12-31 | $1,539,982 | 52,884 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $1,982,858 | 80,933 | Shares | Defined | 2022-11-16 | |
| 2022-06-30 | $85,431 | 20,586 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $135,521 | 11,764 | Shares | Defined | 2022-05-18 | |
| 2021-12-31 | $372,992 | 37,374 | Shares | Defined | 2022-02-09 | |
| 2021-09-30 | $142,458 | 10,908 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $103,715 | 5,297 | Shares | Defined | 2021-08-10 | |
| 2021-03-31 | $313,392 | 14,734 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $143,120 | 4,814 | Shares | Defined | 2021-02-10 | |
| 2020-09-30 | $171,496 | 7,914 | Shares | Defined | 2020-10-30 | |
| 2020-06-30 | $59,808 | 2,682 | Shares | Defined | 2020-08-06 | |
| 2020-03-31 | $194,207 | 12,760 | Shares | Defined | 2020-05-13 | |
| No filing history on record for this holder in this stock. | ||||||